Home6Y4 • FRA
add
Vicore Pharma Holding AB
Previous close
€0.69
Day range
€0.72 - €0.72
Year range
€0.52 - €1.95
Market cap
1.84B SEK
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 892.00K | -99.14% |
Operating expense | 92.44M | 18.40% |
Net income | -111.54M | -451.68% |
Net profit margin | -12.50K | -41,204.27% |
Earnings per share | -0.48 | — |
EBITDA | -90.98M | -436.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.05B | 104.77% |
Total assets | 1.08B | 100.37% |
Total liabilities | 63.08M | 21.70% |
Total equity | 1.02B | — |
Shares outstanding | 232.36M | — |
Price to book | 0.16 | — |
Return on assets | -20.02% | — |
Return on capital | -21.29% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -111.54M | -451.68% |
Cash from operations | -86.11M | -473.04% |
Cash from investing | -333.85M | -576.92% |
Cash from financing | — | — |
Net change in cash | -440.53M | -551.61% |
Free cash flow | -70.88M | -611.14% |
About
Founded
2000
Website
Employees
29
